Explore the vast range of titles available.

Telomeres are guanine-rich sequences that protect the ends of chromosomes. These regions can fold into G-quadruplex structures and their stabilization by G-quadruplex ligands has been employed as an anticancer strategy. Genetic analysis in human telomeres revealed extensive allelic variation restricted to loop bases, indicating that the variant telomeric sequences maintain the ability to fold into G-quadruplex. To assess the effect of mutations in loop bases on G-quadruplex folding and stability, we performed a comprehensive analysis of mutant telomeric sequences by spectroscopic techniques, molecular dynamics simulations and gel electrophoresis. We found that when the first position in the loop was mutated from T to C or A the resulting structure adopted a less stable antiparallel topology; when the second position was mutated to C or A, lower thermal stability and no evident conformational change were observed; in contrast, substitution of the third position from A to C induced a more stable and original hybrid conformation, while mutation to T did not significantly affect G-quadruplex topology and stability. Our results indicate that allelic variations generate G-quadruplex telomeric structures with variable conformation and stability. This aspect needs to be taken into account when designing new potential anticancer molecules.

Naphthalene diimide (NDI) derivatives have shown high affinity for telomeric guanine (G)-quadruplexes and good antiproliferative activity in different human tumor experimental models. A trisubstituted compound (H-NDI-NMe2) has been reported to stabilize the telomeric G-quadruplex and to cause telomere dysfunction and downregulation of telomerase expression. We further investigated its mechanism of action by analyzing the capability of the molecule to interfere with the expression levels of oncogenes, such as MYC, telomerase reverse transcriptase (TERT), KIT and BCL2, known to bear G-quadruplex-forming sequences within their promoters, in human tumor cell lines of different histological origin. Exposure to H-NDI-NMe2 resulted in a cell type-dependent perturbation of the expression levels of the four selected genes. Biophysical and molecular analyses revealed that H-NDI-NMe2 bound with high affinity and effectively stabilized mainly MYC and BCL2, which share long sequences and the possibility of multiple G-quadruplex folding. The mRNA levels of both genes, but not protein amounts were affected by NDI treatment. Global gene expression analysis showed modulation of genes implicated in telomere function and mechanisms of cancer; however, G-quadruplex-mediated regulation of gene expression by H-NDI-NMe2 was largely dependent on the cell context. These data indicate that a deeper knowledge on the molecular mechanisms and biological effects of G-quadruplex structures is still needed to help developing new effective anticancer agents.

Although carbonic anhydrase is a ubiquitous enzyme involved in a variety of physiological processes, the information on its evolution and cold adaptation among Antarctic fish is still limited: the only Antarctic fish carbonic anhydrase characterized up-to-date is from Chionodraco hamatus, a member of the Channichthyidae family. In this work, we characterized orthologous genes within two other fish families: Nototheniidae ( Trematomus eulepidotus, Trematomus lepidorhinus, Trematomus bernacchii ) and Bathydraconidae ( Cygnodraco mawsoni ). The cDNAs of epithelial gill carbonic anhydrases were cloned and sequenced. Both coding and deduced amino acid sequences were used in phylogenetic analyses. The group of enzymes preferentially expressed in fish erythrocytes (CAIIb) represented the most conserved variant. This result suggests that, although the two variants derived from the same ancestor, CAIIc genes have a more complex evolutionary history than CAIIb. The peculiar distribution of Antarctic CAs among fish CAIIcs suggests that the CAIIc gene appeared at different times through independent duplication events, even after the speciation that led to the differentiation of Antarctic fish families. Using the new CA sequences, we built homology models to trace the expected consequences of sequence variability at the protein structure level. From these analyses, we inferred that sequence variability in Antarctic fish CAs affect important physicochemical properties of these proteins and consequentially influence their reactivity. Furthermore, we searched and tested the validity of various potential molecular trademarks for cold adaptation: significant features that can be related to cold adaptation in fish CAs include reduction of positively charged solvent accessible surfaces and an increased flexibility of N-terminal and C-terminal regions.

Telomeres are guanine-rich sequences that protect the ends of chromosomes. These regions can fold into G-quadruplex structures and their stabilization by G-quadruplex ligands has been employed as an anticancer strategy. Genetic analysis in human telomeres revealed extensive allelic variation restricted to loop bases, indicating that the variant telomeric sequences maintain the ability to fold into G-quadruplex. To assess the effect of mutations in loop bases on G-quadruplex folding and stability, we performed a comprehensive analysis of mutant telomeric sequences by spectroscopic techniques, molecular dynamics simulations and gel electrophoresis. We found that when the first position in the loop was mutated from T to C or A the resulting structure adopted a less stable antiparallel topology; when the second position was mutated to C or A, lower thermal stability and no evident conformational change were observed; in contrast, substitution of the third position from A to C induced a more stable and original hybrid conformation, while mutation to T did not significantly affect G-quadruplex topology and stability. Our results indicate that allelic variations generate G-quadruplex telomeric structures with variable conformation and stability. This aspect needs to be taken into account when designing new potential anticancer molecules.